XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
Research and development $ 27,585 $ 27,429
In-process research and development   2,000
General and administrative 9,440 7,076
Total operating expenses 37,025 36,505
Loss from operations (37,025) (36,505)
Other income (expense)    
Interest income 3,877 114
Other expense (51) (67)
Total other income (expense), net 3,826 47
Net loss $ (33,199) $ (36,458)
Net loss per share, basic $ (0.22) $ (0.31)
Net loss per share, diluted $ (0.22) $ (0.31)
Weighted-average shares of common stock used in computing net loss per share, basic 149,504,216 119,491,433
Weighted-average shares of common stock used in computing net loss per share, diluted 149,504,216 119,491,433
Other comprehensive income (loss):    
Unrealized gain (loss) on marketable securities, net $ 527 $ (789)
Comprehensive loss $ (32,672) $ (37,247)